ESMV Among Factor ETFs
End-of-day Nov 18, 2026 · 60 Factor ETFs by Max
Getting the latest data.
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.5% | −3.1% | −1.5% | −0.2% | +10.6% | +12.0% | +41.7% | +36.0% | — | +35.6% |
| Peer average | −0.2% | −3.7% | −4.2% | −4.4% | +9.0% | +12.7% | +61.8% | +51.1% | +219.1% | — |
| S&P 500 · VOO | −0.3% | −3.9% | −5.0% | −4.0% | +8.0% | +10.9% | +72.4% | +68.9% | +302.1% | — |
$16 of every $1,000 in ESMV is Travelers
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | TRVTravelers Companies | Financial Services | 1.65% | $164.67 | 329 | $131K |
| 2 | MCKMckesson | Healthcare | 1.64% | $163.55 | 119 | $130K |
| 3 | MSIMotorola Solutions | Technology | 1.60% | $159.64 | 241 | $127K |
| 4 | MSFTMicrosoft | Technology | 1.57% | $156.78 | 246 | $125K |
| 5 | WELLWelltower | Real Estate | 1.56% | $156.25 | 505 | $124K |
| 6 | MAMastercard | Financial Services | 1.54% | $154.46 | 190 | $123K |
| 7 | KOCoca-cola | Consumer Defensive | 1.51% | $151.36 | 1,217 | $120K |
| 8 | GILDGilead Sciences | Healthcare | 1.49% | $149.40 | 697 | $119K |
| 9 | VRTXVertex Pharmaceuticals | Healthcare | 1.45% | $145.27 | 216 | $115K |
| 10 | VVisa | Financial Services | 1.44% | $143.76 | 274 | $114K |
| 11 | MRKMerck | Healthcare | 1.41% | $141.33 | 783 | $112K |
| 12 | BNYBank OF NEW York Mellon | Financial Services | 1.41% | $140.68 | 746 | $112K |
| 13 | VZVerizon Communications | Communication Services | 1.40% | $139.59 | 2,414 | $111K |
| 14 | TXNTexas Instrument | Technology | 1.39% | $138.56 | 372 | $110K |
| 15 | ADPAutomatic Data Processing | Technology | 1.36% | $136.23 | 351 | $108K |
of the $163B in 60 Factor ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | TRV | Travelers Companies | 1.65% |
| 2 | MCK | Mckesson | 1.64% |
| 3 | MSI | Motorola Solutions | 1.60% |
| 4 | MSFT | Microsoft | 1.57% |
| 5 | WELL | Welltower | 1.56% |
| 6 | MA | Mastercard | 1.54% |
| 7 | KO | Coca-cola | 1.51% |
| 8 | GILD | Gilead Sciences | 1.49% |
| 9 | VRTX | Vertex Pharmaceuticals | 1.45% |
| 10 | V | Visa | 1.44% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 15, 2026 | Sep 18, 2026 | $0.11 |
| Jun 15, 2026 | Jun 18, 2026 | $0.0858 |
| Mar 17, 2026 | Mar 20, 2026 | $0.12 |
| Dec 16, 2025 | Dec 19, 2025 | $0.13 |
| Sep 16, 2025 | Sep 19, 2025 | $0.13 |
| Jun 16, 2025 | Jun 20, 2025 | $0.10 |
| Mar 18, 2025 | Mar 21, 2025 | $0.0888 |
| Dec 17, 2024 | Dec 20, 2024 | $0.15 |
| Sep 25, 2024 | Sep 30, 2024 | $0.12 |
| Jun 11, 2024 | Jun 17, 2024 | $0.10 |
| Mar 21, 2024 | Mar 27, 2024 | $0.11 |
| Dec 20, 2023 | Dec 27, 2023 | $0.13 |